L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors

Kwangsoo Kim, Jae Ho Jeong, Daejin Lim, Yeongjin Hong, Hyung Ju Lim, Geun Joong Kim, So Ra Shin, Je Jung Lee, Misun Yun, Robert Harris, Jung Joon Min, Hyon E. Choy

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Bacteria can be engineered to deliver anticancer proteins to tumors via a controlled expression system that maximizes the concentration of the therapeutic agent in the tumor. L-asparaginase (L-ASNase), which primarily converts asparagine to aspartate, is an anticancer protein used to treat acute lymphoblastic leukemia. In this study, Salmonellae were engineered to express L-ASNase selectively within tumor tissues using the inducible araBAD promoter system of Escherichia coli. Antitumor efficacy of the engineered bacteria was demonstrated in vivo in solid malignancies. This result demonstrates the merit of bacteria as cancer drug delivery vehicles to administer cancer-starving proteins such as L-ASNase to be effective selectively within the microenvironment of cancer tissue.

Original languageEnglish (US)
Article number15007
Number of pages1
JournalMolecular Therapy - Oncolytics
Volume2
DOIs
StatePublished - Jun 10 2015

Fingerprint

Asparaginase
Salmonella typhimurium
Neoplasms
Bacteria
Proteins
Tumor Microenvironment
Asparagine
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Aspartic Acid
Salmonella
Escherichia coli
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Cancer Research
  • Pharmacology (medical)

Cite this

Kim, K., Jeong, J. H., Lim, D., Hong, Y., Lim, H. J., Kim, G. J., ... Choy, H. E. (2015). L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors. Molecular Therapy - Oncolytics, 2, [15007]. https://doi.org/10.1038/mto.2015.7

L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors. / Kim, Kwangsoo; Jeong, Jae Ho; Lim, Daejin; Hong, Yeongjin; Lim, Hyung Ju; Kim, Geun Joong; Shin, So Ra; Lee, Je Jung; Yun, Misun; Harris, Robert; Min, Jung Joon; Choy, Hyon E.

In: Molecular Therapy - Oncolytics, Vol. 2, 15007, 10.06.2015.

Research output: Contribution to journalArticle

Kim, K, Jeong, JH, Lim, D, Hong, Y, Lim, HJ, Kim, GJ, Shin, SR, Lee, JJ, Yun, M, Harris, R, Min, JJ & Choy, HE 2015, 'L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors', Molecular Therapy - Oncolytics, vol. 2, 15007. https://doi.org/10.1038/mto.2015.7
Kim, Kwangsoo ; Jeong, Jae Ho ; Lim, Daejin ; Hong, Yeongjin ; Lim, Hyung Ju ; Kim, Geun Joong ; Shin, So Ra ; Lee, Je Jung ; Yun, Misun ; Harris, Robert ; Min, Jung Joon ; Choy, Hyon E. / L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors. In: Molecular Therapy - Oncolytics. 2015 ; Vol. 2.
@article{8ba81990223e46629a4b5d2ed683b5fe,
title = "L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors",
abstract = "Bacteria can be engineered to deliver anticancer proteins to tumors via a controlled expression system that maximizes the concentration of the therapeutic agent in the tumor. L-asparaginase (L-ASNase), which primarily converts asparagine to aspartate, is an anticancer protein used to treat acute lymphoblastic leukemia. In this study, Salmonellae were engineered to express L-ASNase selectively within tumor tissues using the inducible araBAD promoter system of Escherichia coli. Antitumor efficacy of the engineered bacteria was demonstrated in vivo in solid malignancies. This result demonstrates the merit of bacteria as cancer drug delivery vehicles to administer cancer-starving proteins such as L-ASNase to be effective selectively within the microenvironment of cancer tissue.",
author = "Kwangsoo Kim and Jeong, {Jae Ho} and Daejin Lim and Yeongjin Hong and Lim, {Hyung Ju} and Kim, {Geun Joong} and Shin, {So Ra} and Lee, {Je Jung} and Misun Yun and Robert Harris and Min, {Jung Joon} and Choy, {Hyon E.}",
year = "2015",
month = "6",
day = "10",
doi = "10.1038/mto.2015.7",
language = "English (US)",
volume = "2",
journal = "Molecular Therapy - Oncolytics",
issn = "2372-7705",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors

AU - Kim, Kwangsoo

AU - Jeong, Jae Ho

AU - Lim, Daejin

AU - Hong, Yeongjin

AU - Lim, Hyung Ju

AU - Kim, Geun Joong

AU - Shin, So Ra

AU - Lee, Je Jung

AU - Yun, Misun

AU - Harris, Robert

AU - Min, Jung Joon

AU - Choy, Hyon E.

PY - 2015/6/10

Y1 - 2015/6/10

N2 - Bacteria can be engineered to deliver anticancer proteins to tumors via a controlled expression system that maximizes the concentration of the therapeutic agent in the tumor. L-asparaginase (L-ASNase), which primarily converts asparagine to aspartate, is an anticancer protein used to treat acute lymphoblastic leukemia. In this study, Salmonellae were engineered to express L-ASNase selectively within tumor tissues using the inducible araBAD promoter system of Escherichia coli. Antitumor efficacy of the engineered bacteria was demonstrated in vivo in solid malignancies. This result demonstrates the merit of bacteria as cancer drug delivery vehicles to administer cancer-starving proteins such as L-ASNase to be effective selectively within the microenvironment of cancer tissue.

AB - Bacteria can be engineered to deliver anticancer proteins to tumors via a controlled expression system that maximizes the concentration of the therapeutic agent in the tumor. L-asparaginase (L-ASNase), which primarily converts asparagine to aspartate, is an anticancer protein used to treat acute lymphoblastic leukemia. In this study, Salmonellae were engineered to express L-ASNase selectively within tumor tissues using the inducible araBAD promoter system of Escherichia coli. Antitumor efficacy of the engineered bacteria was demonstrated in vivo in solid malignancies. This result demonstrates the merit of bacteria as cancer drug delivery vehicles to administer cancer-starving proteins such as L-ASNase to be effective selectively within the microenvironment of cancer tissue.

UR - http://www.scopus.com/inward/record.url?scp=85006131544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006131544&partnerID=8YFLogxK

U2 - 10.1038/mto.2015.7

DO - 10.1038/mto.2015.7

M3 - Article

AN - SCOPUS:85006131544

VL - 2

JO - Molecular Therapy - Oncolytics

JF - Molecular Therapy - Oncolytics

SN - 2372-7705

M1 - 15007

ER -